Cover Image

Analysis of Drug Utilization in Patients with Psoriasis: A Real-World Retrospective Study Among the Italian Population

Valentina Perrone,1 Serena Losi,2 Silvia Sabatino,2 Maurizio Mezzetti,3 Melania Dovizio,1 Diego Sangiorgi,1 Luca Degli Esposti1 1CliCon S.r.l., Società Benefit-Health Economics and Outcomes Research, Bologna, 40137, Italy; 2Eli Lilly Italy S.p.A, Sesto Fiorentino, Italy; 3Eli Lilly Italy S.p.A, Rome...

Full description

Saved in:

Bibliographic Details
Main Authors:	Perrone V (Author), Losi S (Author), Sabatino S (Author), Mezzetti M (Author), Dovizio M (Author), Sangiorgi D (Author), Degli Esposti L (Author)
Format:	Book
Published:	Dove Medical Press, 2023-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of the Therapeutic Pattern and Pharmaco-Utilization in Hypercholesterolemic Patients Treated with Statins: A Retrospective Study on Italian Real-World Data
by: Perrone V, et al.
Published: (2022)

Topical medication utilization and health resources consumption in adult patients affected by psoriasis: findings from the analysis of administrative databases of local health units
by: Perrone V, et al.
Published: (2017)

Residual cardiovascular risk in patients who received lipid-lowering treatment in a real-life setting: retrospective study
by: Perrone V, et al.
Published: (2016)

Analysis of Patients’ Characteristics and Treatment Profile of People Who Use Drugs (PWUDs) with and without a Co-Diagnosis of Viral Hepatitis C: A Real-World Retrospective Italian Analysis
by: Nava FA, et al.
Published: (2023)

Disease progression and health care resource consumption in patients affected by hepatitis C virus in real practice setting
by: Perrone V, et al.
Published: (2016)

Cardiovascular Risk Profile in Prostate Cancer Patients Treated with GnRH Agonists versus Antagonists: An Italian Real-World Analysis
by: Perrone V, et al.
Published: (2020)

Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs
by: L. Degli Esposti, et al.
Published: (2021)

Drug adherence to olmesartan/amlodipine fixed combination in an Italian clinical practice setting
by: Degli Esposti L, et al.
Published: (2014)

Treatment Pattern Analysis and Health-care Resource Consumption on Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Biological Drugs in a Northern Italian Region
by: Perrone V, et al.
Published: (2020)

Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug–Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA)
by: Fagiuoli S, et al.
Published: (2023)

Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis)
by: D. Orsini, et al.
Published: (2024)

Direct Healthcare Costs by Level of Adherence of a Real-World Population of Statin Users in Italy
by: Degli Esposti L, et al.
Published: (2022)

Seriousness, preventability, and burden impact of reported adverse drug reactions in Lombardy emergency departments: a retrospective 2-year characterization
by: Perrone V, et al.
Published: (2014)

Epidemiology, Patients' Journey and Healthcare Costs in Early-Stage Non-Small-Cell Lung Carcinoma: A Real-World Evidence Analysis in Italy
by: Diego Luigi Cortinovis, et al.
Published: (2023)

Adherence and resource use among patients treated with biologic drugs: findings from BEETLE study
by: Degli Esposti L, et al.
Published: (2014)

Drug Utilization and Measurement of Medication Adherence: A Real World Study of Psoriasis in Italy
by: Sara Mucherino, et al.
Published: (2023)

Explorative analysis of gender-specific characteristics in patients with heart failure in an Italian hospital
by: Perrone V, et al.
Published: (2019)

Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients
by: Perrone V, et al.
Published: (2014)

Analysis of disease patterns and cost of treatments for prevention of deep venous thrombosis after total knee or hip replacement: results from the Practice Analysis of THromboprophylaxis after Orthopaedic Surgery (PATHOS) study
by: Degli Esposti L, et al.
Published: (2012)

Effectiveness and Safety After a Switch to Tildrakizumab: A Real World Multicenter Italian Study in Psoriasis
by: Eugenia Veronica Di Brizzi, et al.
Published: (2023)

Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience-IL PSO (Italian Landscape Psoriasis)
by: Diego Orsini, et al.
Published: (2024)

Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces
by: Martina Vispi, et al.
Published: (2020)

Drug utilization research in Peru: Is real-world data available?
by: L. Yesenia Rodríguez-Tanta, et al.
Published: (2023)

Real-world Data Reveal Long Drug Survival for Guselkumab in Patients with Plaque Psoriasis
by: Marloes E. van Muijen, et al.
Published: (2022)

Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases
by: Degli Esposti L, et al.
Published: (2013)

Real‐world drug survival of Brodalumab, in patients with psoriasis switched from Ixekizumab: Results of a single centre retrospective study (BroSwitch)
by: Jolijn C. Bethlem, et al.
Published: (2023)

Long-Term Effectiveness of Brodalumab for the Treatment of Moderate-To-Severe Psoriasis: A Real-Life Multicenter Study of Up to 3 Years in a Real-Life Italian Cohort
by: Giacomo Caldarola, et al.
Published: (2024)

Intersocietal survey on real-world asthma management in Italian children
by: Maria Angela Tosca, et al.
Published: (2024)

Epidemiology, patient profile, and health care resource use for hepatitis C in Italy
by: Sangiorgi D, et al.
Published: (2017)

The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios
by: Rajagopalan M, et al.
Published: (2021)

Expert survey on real‐world data utilization and real‐world evidence generation for regulatory decision‐making in drug lifecycle in Korea
by: Hankil Lee, et al.
Published: (2024)

Persistence, switch rates, drug consumption and costs of biological treatment of rheumatoid arthritis: an observational study in Italy
by: Degli Esposti L, et al.
Published: (2016)

Real-World Experience of Bimekizumab in an Elderly Patients Cohort with Plaque-Type Psoriasis: A 24-Week Retrospective Study
by: Fratton Z, et al.
Published: (2024)

Real-world biologic treatment patterns and healthcare resource utilization in psoriasis patients using an insurance claims database in Japan
by: Celine Miyazaki, et al.
Published: (2024)

Real-World Experience of Methotrexate in the Treatment of Skin Diseases: an Italian Delphi Consensus
by: Giovanni Damiani, et al.
Published: (2023)

Adherence to statin treatment following a myocardial infarction: an Italian population-based survey
by: Monaldi B, et al.
Published: (2015)

Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: a 52-week Italian real-life experience
by: Giacomo Caldarola, et al.
Published: (2023)

Real-world outcomes and drug survival of brodalumab: results from the German Psoriasis Registry PsoBest
by: Lisa Schaeffer, et al.
Published: (2024)

Single-Centre Real-World Study on Drug Survival and Effectiveness of Brodalumab for Treatment of Psoriasis and Psoriatic Arthritis
by: Cathrine Dawn Büttner Elgaard, et al.
Published: (2023)

Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)
by: Andrea Chiricozzi, et al.
Published: (2023)